Diego Rincon-Limas

Can SARS-CoV-2 proteins accelerate Abeta pathology in fly and mouse models of AD?

Nuclear import receptors as modifiers of TDP-43 phase transition and toxicity in FTD/ALS

Harnessing new targets and mechanisms mediating AD pathogenesis

Functional assessment of 1,500 human genes against coexistent Abeta and tau pathology in vivo

Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer’s disease

Exploring the unparalleled protection of RAF2 against Abeta42 and tau toxicity

Uncovering targets that block pathological interactions between Abeta and tau

Large-scale identification of genes that suppress concurrent Abeta42 and tau pathology in vivo

Targeting nuclear transport dysfunction in TDP-43 proteinopathies

Optogenetic systems to regulate light-mediated transcription with spatiotemporal resolution

Optogenetic modeling of primary and secondary CNS proteinopathies in Drosophila

Engineering chaperones for extracellular amyloids